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The Centers for Disease Control and Prevention (CDC) and the Drug Enforcement Administration (DEA) are investigating 
recent increases in fentanyl-related unintentional overdose fatalities in multiple states across the U.S. The purpose of this 
HAN advisory is to: (1) alert public health departments, health care providers, first responders, and medical examiners 
and coroners to the possibility of additional increases in other jurisdictions, (2) provide recommendations for improving 
detection of fentanyl-related overdose outbreaks and (3) encourage states to expand access to naloxone and training for 
administering naloxone to reduce opioid overdose deaths. 
 
Background 
Fentanyl, a synthetic and short-acting opioid analgesic, is 50-100 times more potent than morphine and approved for 
managing acute or chronic pain associated with advanced cancer.1 Although pharmaceutical fentanyl can be diverted for 
misuse, most cases of fentanyl-related morbidity and mortality have been linked to illicitly manufactured fentanyl and 
fentanyl analogs, collectively referred to as non-pharmaceutical fentanyl (NPF).2 NPF is sold via illicit drug markets for its 
heroin-like effect and often mixed with heroin and/or cocaine as a combination product—with or without the user’s 
knowledge—to increase its euphoric effects. While NPF-related overdoses can be reversed with naloxone, a higher dose 
or multiple number of doses per overdose event may be required to revive a patient due to the high potency of NPF. 3,4 
 
In March 2015, DEA issued a nationwide alert identifying fentanyl as a threat to public health and safety. 5  This was 
followed by a DEA National Heroin Threat Assessment Summary, which noted that “beginning in late 2013 and 
throughout 2014, several states have reported spikes in overdose deaths due to fentanyl and its analog acetyl-fentanyl.” 6 
Similar to previous fentanyl overdose outbreaks, most of the more than 700 fentanyl-related overdose deaths reported to 
DEA during this timeframe were attributable to illicitly-manufactured fentanyl—not diverted pharmaceutical fentanyl—and 
either mixed with heroin or other diluents and sold as a highly potent form (sometimes under the street name “China 
White”). The DEA report noted that the “true number is most likely higher because “many coroners’ offices and state crime 
laboratories do not test for fentanyl or its analogs unless given a specific reason to do so.”6   
 
Reports on state drug seizures (or confiscations) from the National Forensic Laboratory Information System (NFLIS), a 
program of the DEA’s Office of Diversion Control, indicate a significant increase in the total number of fentanyl drug 
seizures reported by forensic laboratories around the country from 2012 to 2014 (618 in 2012; 945 in 2013; 4,585 in 
2014).7  More than 80% of drug seizures in 2014 were concentrated in 10 states (Table 1). The number of states reporting 
20 or more fentanyl seizures every six months is increasing. From July to December 2014, 18 states reported 20 or more 
fentanyl drug seizures (See Figure 1). Previously, six states reported 20 or more fentanyl drug seizures from July to 











Number of Fentanyl 
seizures 
1  Ohio 1245 
2  Massachusetts 630 
3  Pennsylvania 419 
4  Maryland 311 
5  New Jersey 238 
6  Kentucky 232 
7  Virginia 222 
8  Florida 183 
9  New Hampshire 177 






These increases raise serious concerns for public health if fentanyl seizures serve as a proxy for increased overdose risk.  
Recent fentanyl-related fatal overdose data from several of the top 10 states with highest seizure counts suggest fatalities 
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have increased in states reporting large increases in fentanyl seizures.  Two of the top-five states, Ohio and Maryland, 
both reported sharp increases in fentanyl-related deaths in 2014—Ohio reported 514 fentanyl-related fatal overdoses in 
2014 compared to 92 in 2013,8 and Maryland reported 185 fentanyl-related fatal overdoses in 2014 compared to 58 in 
20139.  Massachusetts, another top-five state, is currently investigating whether an abnormally sharp increase in opioid-
related deaths in 2014 is attributable to fentanyl.10 Florida, another state reporting increases in fentanyl-related drug 
seizures, recently reported 397 fatal overdoses attributable to fentanyl in 2014, up from 185 in 201311.   
 
Fentanyl poses a significant danger to public health workers, first responders, and law enforcement personnel that may 
unwittingly come into contact with it either by absorbing through the skin or accidental inhalation of airborne powder.  In 
August 2015, New Jersey law enforcement officers conducting a narcotics field test on an illicit substance experienced 
shortness of breath, dizziness, and respiratory distress after coming into contact with an unknown substance, which 
forensic laboratory testing determined to be a mix of cocaine, heroin, and fentanyl. 
 
Recommendations 
CDC suggests the following actions in response to increases in fentanyl-related overdose deaths: 
• Improve detection of fentanyl outbreaks to facilitate effective response. 
o Public health departments: Explore methods for more rapidly detecting drug overdose outbreaks, 
including fentanyl.12 
 Use existing surveillance systems such as medical examiner data, emergency medical services 
data or near real-time emergency department data  
 In outbreak situations of dramatically increased opioid overdose, at sentinel sites, or in 
jurisdictions with high drug overdose burden, consider asking emergency departments to report 
fatal and nonfatal opioid overdose cases to them within 48 hours.13 This may be a resource-
intensive approach.   
 Consider engaging local poison centers to assist with tracking and treatment of patients. 
 Review data on drug seizures involving fentanyl or acetyl-fentanyl within the jurisdiction such as 
those published by National Forensic Laboratory Information System (NFLIS) to stay abreast of 
geographic changes in supply (see NFLIS Report or 
(http://www.deadiversion.usdoj.gov/nflis/spec_rpt_opioids_2014.pdf).  
 Identify and track decedent demographics and risk factors (e.g., drug type and route of 
administration) along with geographic concentrations of cases to better inform public health 
surveillance and overdose prevention efforts.14 
 
o Medical examiners and coroners: Screen for fentanyl in suspected opioid overdose cases in regions 
reporting increases in fentanyl seizures, fentanyl-related overdose fatalities or unusually high spikes in 
heroin or unspecified drug overdose fatalities. Not all jurisdictions routinely test for fentanyl.  
 Screen specimens from fatal drug overdose deaths using an enzyme-linked immunosorbent 
assay (ELISA test) with the capacity to detect fentanyl. If an ELISA test is positive for fentanyl, 
conduct confirmatory testing by gas chromatography/mass spectrometry (GC/MS). If no fentanyl 
is detected by GC/MS, then fentanyl analogs should be suspected and subsequent testing 
considered.15 
 Implement standardized mechanisms for determining cause of death and methods of reporting to 
ensure death reports are complete and accurate.16 SAMHSA has published consensus 
recommendations for uniform standards and case definitions for classifying opioid-related deaths 
(See Consensus Recommendations or 
http://www.tandfonline.com/doi/pdf/10.1080/10550887.2013.824334). It is especially important to 
include the word “fentanyl” on the death certificate when the drug is a contributing cause of death. 
 
o Law enforcement: Law enforcement can play an important role identifying and responding to increases in 
the distribution and use of illicitly manufactured fentanyl. 
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 Investigating officers are advised to consider the potential exposure to fentanyl through skin 
exposure and/or inhalation of aerosolized drug, and utilize appropriate safety precautions and 
personal protective equipment17. 
 Test drug samples seized or collected by law enforcement or found at the scene of death to 
detect fentanyl or fentanyl analogs.18  
 Prioritize and expedite testing of drug samples taken from drug overdose scenes, if possible. 
 Share data on fentanyl and acetyl-fentanyl drug seizures with local health departments, coroners, 
and medical examiners.   
 
• Expand Use of Naloxone: Naloxone is a safe and effective antidote to all opioid-related overdoses, including 
heroin and fentanyl, and is a critical tool in preventing fatal opioid overdoses.19,20  Depending on state and local 
laws, this medication can potentially be administered effectively by EMS, law enforcement21, people at high risk 
for overdose22, or family and friend bystanders who have obtained the medication23,  
o Health Care Providers: Multiple doses of naloxone may need to be administered per overdose event 
because of fentanyl’s increased potency relative to other opioids.3  
 Increase the amount of naloxone on hand for first responders such as law enforcement and other 
EMS personnel given the increased amount needed and rate of use during a fentanyl outbreak4  
 Recognize and treat opioid overdose patients, with particular focus on how to respond to fentanyl 
and acetyl fentanyl overdose.4 
o Harm reduction organizations: Expand naloxone access to persons at risk for opioid-related overdose and 
their family members.24 
 Provide take-home naloxone kits and encourage people who use heroin and/or misuse opioid 
analgesics—or know people that do—to carry them. 
 Train those using drugs how to effectively administer naloxone and emphasize the importance of 
overdose prevention tactics, such as rescue breathing and calling 911. 
 
 
For more information 
• CDC Health Advisory: Recommendations for Laboratory Testing for Acetyl Fentanyl and Patient Evaluation and 
Treatment for Overdose with Synthetic Opioid at http://emergency.cdc.gov/han/han00350.asp  
• DEA Issues Nationwide Alter on Fentanyl as Threat to Health and Public Safety at 
http://www.dea.gov/divisions/hq/2015/hq031815.shtml  
• Fentanyl SAMHSA letter to physicians and fact sheet at: 
http://buprenorphine.samhsa.gov/20130715114030811.pdf   
• Special Report: Opiates and Related Drugs Reported in NFLIS, 2009-2014 at 
http://www.deadiversion.usdoj.gov/nflis/spec_rpt_opioids_2014.pdf  
• SAMHSA Opioid Overdose Toolkit at: http://store.samhsa.gov/shin/content/SMA13-
4742/Overdose_Toolkit_2014_Jan.pdf   
• Call Poison Control at 1-800-222-1222 or use the webPOISONCONTROL® online tool for guidance 
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The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and controlling 
diseases and injuries; enhances health decisions by providing credible information on critical health issues; and promotes 




Categories of Health Alert Network messages:  
Health Alert  Requires immediate action or attention; highest level of importance 
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Health Advisory May not require immediate action; provides important information for a specific incident or 
situation 
Health Update   Unlikely to require immediate action; provides updated information regarding an incident or 
situation 
HAN Info Service Does not require immediate action; provides general public health information 
  
##This message was distributed to state and local health officers, state and local epidemiologists, state and local 
laboratory directors, public information officers, HAN coordinators, and clinician organizations## 
 
